Patents by Inventor John W. Fuseler, JR.

John W. Fuseler, JR. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9132280
    Abstract: A method of photodynamic therapy to treat diseased cells in an animal is generally provided. According to the method, 5-amino-2,2-dimethyl-6-[3?-(R,S)amino-4?-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is administered to the animal such that the 5-amino-2,2-dimethyl-6-[3?-(R,S)amino-4?-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof accumulates in the diseased cells. Then, the diseased cells containing 5-amino-2,2-dimethyl-6-[3?-(R,S)amino-4?-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is exposed to light energy (e.g., ultraviolet light).
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: September 15, 2015
    Assignee: University of South Carolina
    Inventors: Brian Furmanski, Roy E. Wuthier, John W. Fuseler, Jr.
  • Publication number: 20090258941
    Abstract: A method of photodynamic therapy to treat diseased cells in an animal is generally provided. According to the method, 5-amino-2,2-dimethyl-6-[3?-(R,S)amino-4?-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is administered to the animal such that the 5-amino-2,2-dimethyl-6-[3?-(R,S)amino-4?-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof accumulates in the diseased cells. Then, the diseased cells containing 5-amino-2,2-dimethyl-6-[3?-(R,S)amino-4?-hydroxy-butan-1-one]-2,3-dihydro-4H-1-benzopyran-4-one or an analog thereof is exposed to light energy (e.g., ultraviolet light).
    Type: Application
    Filed: April 13, 2009
    Publication date: October 15, 2009
    Applicant: UNIVERSITY OF SOUTH CAROLINA
    Inventors: Brian Furmanski, Rov E. Wuthier, John W. Fuseler, JR.